Stock research
ELAN Elanco Animal Health Incorporated
Healthcare • Drug Manufacturers - Specialty & Generic
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides...…
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
ALL change
-28.12%
Range high
$36.72
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in ELAN?
Price
Showing ALL history. Source: FMP historical price full.
- Prev Close
- $26.39
- Day High
- $26.87
- Day Low
- $25.93
- 52w High
- $27.72
- 52w Low
- $13.39
- Volume
- 1,751,434
- Avg Volume
- Beta
- 1.685
* TTM/most recent where available
Company
- Ticker
- ELAN
- Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- US
- CEO
- Jeffrey N. Simmons
- Employees
- 9900
- Website
- www.elanco.com
Key Metrics
- Market Cap
- 13.1B
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).